Andrew Spencer*
The most well-known and dangerous critical malignant brain growth, Glioblastoma (GBM), accounts for more than 60% of all adult-onset brain malignancies. The incidence of GBM has increased over the previous ten years and is currently 3.21 per 100,000 people worldwide. Despite some long-term improvements, patients with GBM continue to have a horribly unfavorable outlook with a median survival time of about 15 months and a 5-year survival rate of about 5%.
English 
Spanish 
Chinese 
Russian 
German 
French 
Portuguese 
Hindi